Conduit Pharmaceuticals Inc. (NASDAQ:CDTTW) Short Interest Update

Conduit Pharmaceuticals Inc. (NASDAQ:CDTTW) was the recipient of a large growth in short interest in December. As of December 15th, there was short interest totalling 110,600 shares, a growth of 116.0% from the November 30th total of 51,200 shares. Based on an average daily volume of 20,000 shares, the short-interest ratio is currently 5.5 days.

Conduit Pharmaceuticals Price Performance

Conduit Pharmaceuticals stock opened at $0.01 on Friday. Conduit Pharmaceuticals has a 52 week low of $0.01 and a 52 week high of $0.15. The business’s fifty day moving average is $0.01 and its two-hundred day moving average is $0.02.

Conduit Pharmaceuticals Company Profile

Conduit Pharmaceuticals Inc, a clinical-stage specialty biopharmaceutical company, develops pharmaceutical products that provides unmet medical needs in the areas of autoimmune diseases and idiopathic male infertility. Its pipeline includes AZD1656, which has completed Phase I trials for the treatment of type 2 diabetes, renal transplant, Hashimoto's thyroiditis and Grave's disease, uveitis, and preterm labor; and AZD5904, which has completed Phase I clinical trials for the treatment of idiopathic male infertility.